All are true regarding treatment of Guillain-Barre syndrome, EXCEPT:
In the vast majority of patients with GBS, treatment should be initiated as soon after diagnosis as possible. 2 weeks after the first motor symptoms, immunotherapy is no longer effective. Either high-dose intravenous immune globulin (IVIg) or plasmapheresis can be initiated, as they are equally effective. A combination of the two therapies is not significantly better than either alone. Glucocoicoid administration does not shoen the course or prognosis of GBS.
Coicosteroid are used for early recovery and to prevent complications
High-dose intravenous immune globulin can be initiated
Plasmapheresis can be indicated
High-dose intravenous immune globulin and plasmapheresis are equally effective